Abstract
Vascular nitrate tolerance is often accompanied by changes in the activity and/or expression of a number of proteins. However, it is not known whether these changes are associated with the vasodilatory properties of nitrates, or with their tolerance mechanisms. We examined the hemodynamic effects and vascular gene expressions of 2 nitric oxide (NO) donors: nitroglycerin (NTG) and S-nitroso-N-acetylpenicillamine (SNAP). Rats received 10 μg/min NTG, SNAP, or vehicle infusion for 8 hours. Hemodynamic tolerance was monitored by the maximal mean arterial pressure (MAP) response to a 30-μg NTG or SNAP bolus challenge dose (CD) at various times during infusion. Gene expression in rat aorta after NTG or SNAP treatment was determined using cDNA microarrays, and the relative differences in expression after drug treatment were evaluated using several statistical techniques. MAP response of the NTG CD was attenuated from the first hour of NTG infusion (P<.001, analysis of variance [ANOVA]), but not after SNAP (P>.05, ANOVA) or control infusion (P> .05, ANOVA). Student t-statistics revealed that 447 rat genes in the aorta were significantly altered by NTG treatment (P <.05). An adjusted t-statistic approach using resampling techniques identified a subset of 290 genes that remained significantly different between NTG treatment vs control. In contrast, SNAP treatment resulted in the up-regulation of only 7 genes and the downregulation of 34 genes. These results indicate that continuous NTG infusion induced widespread changes in vascular gene expression, many of which are consistent with the multifactorial and complex mechanisms reported for nitrate tolerance.
Similar content being viewed by others
References
Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987; 84: 9265–9269.
Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987; 327: 524–526.
Feelisch M. The use of nitric oxide donors in pharmacological studies. Naunyn Schmiedebergs Arch Pharmacol. 1998; 358: 113–122.
Tseng CM, Tabrizi-Fard MA, Fung HL. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation. J Pharmacol Exp Ther. 2000; 292: 737–742.
Fung HL, Bauer JA. Mechanisms of nitrate tolerance. Cardiovasc Drugs Ther. 1994; 8: 489–499.
Needleman P, Johnson EM, Jr. Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther. 1973; 184: 709–715.
Fung HL, Piliszczuk R. Nitrosothiol and nitrate tolerance. Z Kardiol. 1986; 75: 25–27.
Axelsson KL, Andersson RG. Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover. Eur J Pharmacol. 1983; 88: 71–79.
Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance: a novel mechanism underlying tolerance and crosstolerance. J Clin Invest. 1995; 95: 187–194.
Munzel T, Giaid A, Kurz S, Stewart DJ, Harrison DG. Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance. Proc Natl Acad Sci USA. 1995; 92: 5244–5248.
Munzel T, Li H, Mollnau H, et al. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability. Circ Res. 2000; 86: E7-E12.
Lander ES. Array of hope. Nat Genet. 1999; 21: 3–4.
Taniguchi M, Miura K, Iwao H, Yamanaka S. Quantitative assessment of DNA microarrays--comparison with Northern blot analyses. Genomics. 2001; 71: 34–39.
Gow AJ, Stamler JS. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature. 1998; 391: 169–173.
Lipton AJ, Johnson MA, Macdonald T, Lieberman MW, Gozal D, Gaston B. S-nitrosothiols signal the ventilatory response to hypoxia. Nature. 2001; 413: 171–174.
Kowaluk EA, Poliszczuk R, Fung HL. Tolerance to relaxation in rat aorta: comparison of an S-nitrosothilol with nitroglycerin. Eur J Pharmacol. 1987; 144: 379–383.
Bauer JA, Fung HL. Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure. J Pharmacol Exp Ther. 1991; 256: 249–254.
Matsumoto T, Takahashi M, Nakae I, Kinoshita M. Vasorelaxing effect of S-nitrosocaptopril on dog coronary arteries: no crosstolerance with nitroglycerin. J Pharmacol Exp Ther. 1995; 275: 1247–1253.
Schuchhardt J, Beule D, Malik A, et al. Normalization strategies for cDNA microarrays. Nucleic Acids Res. 2000; 28: E47:i–v.
Lee ML, Kuo FC, Whitmore GA, Sklar J. Importance of replication in microarray gene expression studies statistical methods and evidence from repetitive cDNA hybridizations. Proc Natl Acad Sci USA. 2000; 97: 9834–9839.
Good P. Resampling Methods: A Practical Guide to Data Analysis. New York, NY: Springer-Verlag: 1999.
Edgington E. Randonization Tests. New York, NY: Marcel Dekker, Inc.; 1980.
Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 1985; 39: 783–791.
Excoffier L, Smouse PE, Quattro JM. Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics. 1992; 131: 479–491.
Carpenter J, Bithell J. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med. 2000; 19: 1141–1164.
Westfall PH, Young SS. Resampling-based Multiple Testing: Examples and Methods for p-adjustment. New York, NY: Wiley: 1993.
Kerr MK, Churchill GA. Bootstrapping cluster analysis: assessing the reliability of conclusions from microarray experiments. Proc Natl Acad Sci USA. 2001; 98: 8961–8965.
Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001; 98: 5116–5121.
Herwig R, Aanstad P, Clark M, Lehrach H. Statistical evaluation of differential expression on cDNA nylon arrays with replicated experiments. Nucleic Acids Res. 2001; 29: E117: 1–9.
Kowaluk EA, Fung HL. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J Pharmacol Exp Ther. 1990; 255: 1256–1264.
Liu L, Hausladen A, Zeng M, Que L, Heitman J, Stamler JS. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature. 2001; 410: 490–494.
Yamamoto T, Bing RJ. Nitric oxide donors. Proc Soc Exp Biol Med. 2000; 225: 200–206.
Miller RA, Galecki A, Shmookler-Reis RJ. Interpretation, design, and analysis of gene array expression experiments. J Gerontol A Biol Sci Med Sci. 2001; 56: B52–57.
Dudoit S, Yang YH, Callow M, Speed T. Statistical methods for identifying differentially expressed genes in replicated cDNA microarry experiments. UC Berkeley, Technical report #578, 2000.
Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solution. J Cardiovasc Pharmacol. 1991; 17: S25-S33.
Bennett BM, McDonald BJ, Nigam R, Simon WC. Biotransformation of organic nitrates and vascular smooth muscle cell function. Trends Pharmacol Sci. 1994; 15: 245–249.
Xuan YT, Guo Y, Han H, Zhu Y, Bolli R. An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci USA. 2001; 98: 9050–9055.
Huber A, Neuhuber WL, Klugbauer N, Ruth P, Allescher HD. Cysteine-rich protein 2, a novel substrate for cGMP kinase I in enteric neurons and intestinal smooth muscle. J Biol Chem. 2000; 275: 5504–5511.
Wolin MS. Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol. 2000; 20: 1430–1442.
Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 1999; 85: 753–766.
Fox PL, Mazumder B, Ehrenwald E, Mukhopadhyay CK. Ceruloplasmin and cardiovascular disease. Free Radic Biol Med. 2000; 28: 1735–1744.
Floris G, Medda R, Padiglia A, Musci G. The physiopathological significance of ceruloplasmin: a possible therapeutic approach. Biochem Pharmacol. 2000; 60: 1735–1741.
Meininger CJ, Marinos RS, Hatakeyama K, et al. Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency. Biochem J. 2000; 349: 353–356.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published: May 7, 2002
Rights and permissions
About this article
Cite this article
Wang, E.Q., Lee, WI., Brazeau, D. et al. cDNA Microarray analysis of vascular gene expression after nitric oxide donor infusion in rats: Implications for nitrate tolerance mechanisms. AAPS PharmSci 4, 10 (2002). https://doi.org/10.1208/ps040208
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/ps040208